Cerebral Therapeutics™ to Present Clinical Data at Antiepileptic Drug and Device Trials XV Conference
Cerebral Therapeutics™, a clinical-stage pharmaceutical company developing specialty medications for uncontrolled neurological diseases, announced today that the Company will present at the Antiepileptic Drug and Device (AEDD) Trials XV conference, which is held every two years and is sponsored by The Epilepsy Study Consortium in collaboration with the University of Pennsylvania and the Epilepsy Foundation.
